MedPath

IMIPENEM AND CILASTATIN FOR INJECTION, USP

IMIPENEM AND CILASTATIN FOR INJECTION, USP

Discontinued
DIN Number

02439840

Drug Class

Human

Market Date

N/A

Company
HC

Methapharm Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02439840
AIG Number0218820002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DH51 IMIPENEM AND CILASTATIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.07.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

CILASTATIN (CILASTATIN SODIUM)Active
Strength: 250 MG / VIAL
Monograph: CILASTATIN (CILASTATIN SODIUM)
IMIPENEMActive
Strength: 250 MG / VIAL
Monograph: IMIPENEM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.